ADMA Biologics, Inc. (ADMA) key performance indicators and operating metrics (4 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization | 59.7M | FY2026-Q1 |
| Adjusted Net Income | 40.7M | FY2026-Q1 |
| Corporate Gross Margin | 63.80 percent | FY2025-Q4 |
| Consolidated Gross Margin | 56.30 percent | FY2025-Q3 |
Back to ADMA overview · ADMA earnings · ADMA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.